Exercise and Vascular Function in Haemodialysis Patients
NCT ID: NCT01591876
Last Updated: 2013-03-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE2
50 participants
INTERVENTIONAL
2012-11-30
2014-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Exercise on Physical Fitness Among Hemodialysis Patients With Chronic Kidney Disease
NCT03579537
Intradialisis Physical Exercise in Quality of Life and Health
NCT05207527
Trial of Hemodialysis Based Exercise for Strength Improvement Study
NCT01962597
Impact of Exercise on Cognitive Impairment in End-Stage Renal Disease
NCT02145702
Aerobic Exercise in Patients With CKD
NCT04375553
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Higher physical activity and fitness are associated with lower cardiovascular disease and all-cause mortality in haemodialysis patients and the general population. Moreover, physical inactivity is associated with increased arterial stiffness and plaques which narrow heart arteries. Worryingly the haemodialysis population is on average highly inactive with low fitness.
Current research demonstrates that exercise which improves fitness improves arterial health. Increased bloodflow during exercise stimulates the release of nitric oxide causing arteries to dilate. Regular exercise is believed to lead to beneficial remodelling of arteries and lower arterial stiffness. Exercise is reported to improve arterial function across a range of conditions. However published research regarding the possible benefits of long term aerobic exercise on arterial health in this population is conflicting. Limitations in study design, moderately high participant dropout rates and low statistical power hamper a definitive conclusion. Importantly a gold standard measure of arterial function has not been used in previously published studies.
There is ample evidence that exercise programmes in people on dialysis improve fitness, physical function, and quality of life. It is also clear that a state of higher physical activity and fitness is associated with better arterial function in the general population. It would be advantageous for reasons of health counselling to determine whether the process of improving physical fitness and activity levels may also improve arterial health in haemodialysis patients.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Progressive muscle relaxation
As well as usual care participants in the control arm will receive instruction in progressive muscle relaxation.
Progressive Muscle relaxation
This is a sequence of stretching and relaxation of the major muscle groups of the body. Participants are initially given detailed information regarding the technique and then provided with a recorded version which they listen to for 30-40 minutes during dialysis sessions. Participants in this group are offered the exercise programme at the end of three months.
Aerobic exercise
Intervention -moderate intensity aerobic exercise.
Intradialytic aerobic exercise
Participants in the intervention group will undertake moderate intensity aerobic exercise. Exercise modality will be recumbent cycling during the first two hours of haemodialysis sessions. Exercise prescription is set using a graded exercise test and anchored to a perceived level of exertion using the BORG scale. Training stimulus is maintained by the participant by increasing the cycling resistance when perceived exertion drops by one point at the current resistance level. Adherence and training volume is recorded during the intervention period.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intradialytic aerobic exercise
Participants in the intervention group will undertake moderate intensity aerobic exercise. Exercise modality will be recumbent cycling during the first two hours of haemodialysis sessions. Exercise prescription is set using a graded exercise test and anchored to a perceived level of exertion using the BORG scale. Training stimulus is maintained by the participant by increasing the cycling resistance when perceived exertion drops by one point at the current resistance level. Adherence and training volume is recorded during the intervention period.
Progressive Muscle relaxation
This is a sequence of stretching and relaxation of the major muscle groups of the body. Participants are initially given detailed information regarding the technique and then provided with a recorded version which they listen to for 30-40 minutes during dialysis sessions. Participants in this group are offered the exercise programme at the end of three months.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Male or female
* Aged \>18 years
* Written informed consent
Exclusion Criteria
* Unstable cardiovascular conditions
* Recent cerebrovascular event
* Excess inter-dialytic weight gain
* Use of corticosteroids, anabolic therapies,
* Co-morbid catabolic conditions
* Serum potassium regularly \>6mmol/L
* Recent pulmonary thromboembolism
* Psychiatric illness including anxiety, mood and untreated eating disorders
* Infection or course of antibiotics within one month of study period.
* Dementia or severe cognitive impairment.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
British Kidney Patients Association
UNKNOWN
Queen Margaret University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sean Prescott
PhD Research Student
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tom Mercer, Professor
Role: STUDY_DIRECTOR
Queen Margaret University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Monklands Hospital
Airdrie, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Jamie Traynor, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
12/WS/0129
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.